1. Home
  2. ATOS vs BZFD Comparison

ATOS vs BZFD Comparison

Compare ATOS & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • BZFD
  • Stock Information
  • Founded
  • ATOS 2009
  • BZFD 2006
  • Country
  • ATOS United States
  • BZFD United States
  • Employees
  • ATOS N/A
  • BZFD N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • BZFD Movies/Entertainment
  • Sector
  • ATOS Health Care
  • BZFD Consumer Discretionary
  • Exchange
  • ATOS Nasdaq
  • BZFD Nasdaq
  • Market Cap
  • ATOS 107.2M
  • BZFD 98.6M
  • IPO Year
  • ATOS 2012
  • BZFD N/A
  • Fundamental
  • Price
  • ATOS $0.82
  • BZFD $2.09
  • Analyst Decision
  • ATOS Strong Buy
  • BZFD
  • Analyst Count
  • ATOS 3
  • BZFD 0
  • Target Price
  • ATOS $6.17
  • BZFD N/A
  • AVG Volume (30 Days)
  • ATOS 1.4M
  • BZFD 254.6K
  • Earning Date
  • ATOS 08-15-2025
  • BZFD 08-07-2025
  • Dividend Yield
  • ATOS N/A
  • BZFD N/A
  • EPS Growth
  • ATOS N/A
  • BZFD N/A
  • EPS
  • ATOS N/A
  • BZFD 0.34
  • Revenue
  • ATOS N/A
  • BZFD $188,899,000.00
  • Revenue This Year
  • ATOS N/A
  • BZFD $6.29
  • Revenue Next Year
  • ATOS N/A
  • BZFD $6.16
  • P/E Ratio
  • ATOS N/A
  • BZFD $6.17
  • Revenue Growth
  • ATOS N/A
  • BZFD N/A
  • 52 Week Low
  • ATOS $0.55
  • BZFD $1.61
  • 52 Week High
  • ATOS $1.66
  • BZFD $5.68
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 44.93
  • BZFD 42.29
  • Support Level
  • ATOS $0.84
  • BZFD $2.36
  • Resistance Level
  • ATOS $0.98
  • BZFD $2.63
  • Average True Range (ATR)
  • ATOS 0.05
  • BZFD 0.15
  • MACD
  • ATOS -0.01
  • BZFD -0.03
  • Stochastic Oscillator
  • ATOS 7.65
  • BZFD 3.28

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About BZFD BuzzFeed Inc.

BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.

Share on Social Networks: